Other featured articles
Recommendations for Implementing the No Surprises Act
Schaeffer Initiative experts examine several key implementation questions within the No Surprises Act and discuss options for resolving those questions.
Medicare Payment for Physician-Administered (Part B) Drugs: The Interim Final Rule and a Better Way Forward
A look at how policymakers can reform an interim-final rule to use Medicare’s demonstration authority under the Center for Medicare and Medicaid Innovation (CMMI) to make large reductions in the amounts it pays physicians for high-cost medicines they administer under Part B.
Expanded Coverage for COVID-19 Testing Must Include Limits On Costs
Schaeffer Initiative experts discuss why the most efficient and equitable way to conduct testing on a mass scale for COVID-19 is through a federally-funded public effort that tests everyone, but until Congress enacts such a program, mandating insurance coverage is an important lever to improve access to testing.
About this section
On this blog, experts from the USC-Brookings Schaeffer Initiative for Health Policy advance the national health policy conversation through innovative ideas and timely, evidence-based analysis. These posts offer policymakers practical recommendations and analysis for solving the health care issues of today.